The University of Iowa Fall 2014

11:30-12:30, Every other Monday

Room B180, Med Labs

Contact: Tel 319-384-4754

Presentations for Fall 2014:

September 1, 2014 Presenter: Labor Day, no journal club

September 15, 2014
Presenter: Kim Morales
Paper: Le A, Stine ZE, Nguyen C, Afzal J, Sun P, Hamaker M, Siegel NM, Gouw AM5, Kang BH, Yu SH, Cochran RL, Sailor KA, Song H, Dang CV. Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia-cell cycle dual reporter. Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12486-91. PMCID: PMC4151727.
[DOI Link,].

September 29, 2014
Presenter: John Lafin
Paper: Bowers LW, Maximo IXF, Brenner AJ, Beeram M, Hursting SD, Price RS, Tekmal RR, Jolly CA, deGraffenried LA. NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions. Cancer Res., 2014;74:4446-4457.
[DOI Link,].

October 13, 2014
Presenter: Somya Kapoor
Paper: Gray MJ, Mhawech-Fauceglia P, Yoo E, Yang W, Wu E, Lee AS, Lin YG. AKT inhibition mitigates GRP78 (glucose-regulated protein) expression and contribution to chemoresistance in endometrial cancers. Int J Cancer. 2013 Jul;133(1):21-30.
PMID: 23280503 PMCID: PMC3633665.
[DOI Link,].

October 27, 2014
Presenter: Cameron Cushing
Paper: Shim H, Wei L, Holder CA, Guo Y, Hu XP, Miller AH, Olson JJ. Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitor. AJR Am J Roentgenol. 2014 Aug;203(2):W158-65. PMID: 25055291.[DOI Link,].

November 10, 2014
Presenter: Jessica Reedy
Paper: Croci DO, Cerliani JP, Dalotto-Moreno T, Mendez-Huergo SP, Mascanfroni ID, Dergan-Dylon S, et al. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell. 2014;156(4):744-58.[DOI Link,].

November 24, 2014
Presenter: Thanksgiving, No journal club

December 8, 2014
Presenter: Madelyn Cotton-Espinosa
Paper: Kohrt HE, Colevas AD, Houot R, Weiskopf K, Goldstein MJ, Lund P, Mueller A, Sagiv-Barfi I, Marabelle A, Lira R, Troutner E, Richards L, Rajapaska A, Hebb J,Chester C, Waller E, Ostashko A, Weng WK, Chen L, Czerwinski D, Fu YX, Sunwoo J, Levy R. Targeting CD137 enhances the efficacy of cetuximab. J Clin Invest. 2014 Jun 2;124(6):2668-82.
[DOI Link,].